AU5623398A - Methods of therapeutic administration of anti-cd40l compounds - Google Patents

Methods of therapeutic administration of anti-cd40l compounds

Info

Publication number
AU5623398A
AU5623398A AU56233/98A AU5623398A AU5623398A AU 5623398 A AU5623398 A AU 5623398A AU 56233/98 A AU56233/98 A AU 56233/98A AU 5623398 A AU5623398 A AU 5623398A AU 5623398 A AU5623398 A AU 5623398A
Authority
AU
Australia
Prior art keywords
methods
therapeutic administration
cd40l compounds
cd40l
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56233/98A
Other languages
English (en)
Inventor
Susan L. Kalled
David W Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of AU5623398A publication Critical patent/AU5623398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56233/98A 1997-03-07 1997-12-31 Methods of therapeutic administration of anti-cd40l compounds Abandoned AU5623398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4015497P 1997-03-07 1997-03-07
US60040154 1997-03-07
PCT/US1997/024133 WO1998039026A2 (en) 1997-03-07 1997-12-31 Methods of therapeutic administration of anti-cd40l compounds

Publications (1)

Publication Number Publication Date
AU5623398A true AU5623398A (en) 1998-09-22

Family

ID=21909414

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56233/98A Abandoned AU5623398A (en) 1997-03-07 1997-12-31 Methods of therapeutic administration of anti-cd40l compounds

Country Status (3)

Country Link
AU (1) AU5623398A (hu)
HU (1) HUP0001263A3 (hu)
WO (1) WO1998039026A2 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2089229C (en) 1992-02-14 2010-04-13 Alejandro A. Aruffo Cd40cr receptor and ligands therefor
CN1173735C (zh) * 1998-04-03 2004-11-03 达特茅斯学院理事 抗-gp39抗体在狼疮及相关肾病的治疗和/或逆转中的应用
EP1101495A4 (en) * 1999-06-01 2003-05-07 Eisai Co Ltd PREVENTIVE AGENTS AGAINST IDIOPATHIC THROMOBOCYTOPENIC PURPURA
DE60035057T2 (de) * 1999-10-04 2008-01-31 Novartis Vaccines and Diagnostics, Inc., Emeryville CD40 Antagonist zur Behandlung von Psoriasis
EP1839674A1 (en) * 1999-10-04 2007-10-03 Novartis Vaccines and Diagnostics, Inc. CD40 antagonist for treating psoriasis
WO2001034194A1 (en) * 1999-11-08 2001-05-17 Idec Pharmaceuticals Corporation Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
US20030170231A1 (en) * 2000-03-06 2003-09-11 Toshihiko Yamauchi Remedies and preventives for antiphospholipid antibody syndrome
AU2001251612A1 (en) 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
CA2781858C (en) 2000-05-12 2015-03-31 Genzyme Corporation Modulators of tnf-.alpha. signaling
WO2001087310A1 (en) * 2000-05-18 2001-11-22 Biotransplant, Inc. Process for reducing antibody response against xenografts
AU8867501A (en) * 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
WO2002022212A2 (en) * 2000-09-18 2002-03-21 Idec Pharmaceuticals Corporation Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
WO2004047825A1 (en) 2002-11-21 2004-06-10 Genzyme Corporation Use of diamide derivatives for inhibiting chronic tissue transplant rejection
DK1562571T3 (da) 2002-11-21 2011-12-05 Genzyme Corp Kombination af et diamidderivat og immunsuppressive midler til hæmning af transplantatafstødning

Also Published As

Publication number Publication date
HUP0001263A3 (en) 2005-11-28
HUP0001263A2 (hu) 2000-08-28
WO1998039026A2 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
AU6491196A (en) Epidural administration of therapeutic compounds with sustained rate of release
AU6094996A (en) Diphosphonate derivatives of therapeutic agents
AU2805195A (en) Therapeutic compounds
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
AU8676698A (en) Devices for providing therapeutic substances
AU5623398A (en) Methods of therapeutic administration of anti-cd40l compounds
AU2939897A (en) Administration of histamine for therapeutic purposes
PL327732A1 (en) Compounds of therapeutic activity
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
GB9700737D0 (en) Administration of drugs
AU6821196A (en) Transdermal administration of vorozole
HUP9901438A3 (en) Therapeutic pyrimidine compounds
AU8816898A (en) Method of drug selection
AU6171196A (en) Therapeutic uses of ta99
AU7641098A (en) Therapeutic composition
AU5330198A (en) Therapeutic compounds
AU4596097A (en) Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives
AU1828399A (en) Novel formulations for the transdermal administration of asimadoline
AU4491697A (en) Compositions of therapeutic agents suitable for oral administration
AUPO480997A0 (en) Therapeutic compounds
AUPO481197A0 (en) Therapeutic compounds
AUPO572197A0 (en) Therapeutic compounds
AUPO624897A0 (en) Therapeutic compounds
AUPN069195A0 (en) Therapeutic compounds
AUPN228095A0 (en) Therapeutic compounds